Thrombosis and COVID-19 vaccines
Article Sidebar
Main Article Content
Abstract
Vaccines against COVID-19 from Moderna Biotech Spain, SL (COVID-19 Vaccine Moderna – mRNA technology), AstraZeneca (Oxford/Astrazeneca Vaccine - ChAdOx1 - adenovirus vector technology) and Janssen-Cilag International NV (COVID-19 Vaccine) Janssen - Ad.26.COV2.S - adenovirus vector technology) used in Europe, the United States and Brazil has presented severe thrombotic adverse reactions. The recorded thrombosis occurred in unusual sites, such as the sagittal venous sinus.
Article Details
Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International 
, allowing their sharing, recognizing the authorship and initial publication in this journal.
Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.
Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.
References
Franchini M, Liumbruno GM, Pezzo M. COVID-19 Vaccine-associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021. https://doi.org/10.1111/ejh.13665 Epub PMid:33987882
Mahase E. COVID-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency. BMJ. 2021;372:n774. https://doi.org/10.1136/bmj.n774 PMid:33741638
Ovadia D, Univadis (Website). No ad Astra Zeneca per i più giovani, sì a vaccini diversi combinati [article in Italian]. 2021 Jun 10 [cited 2021 Jun 20]. Avaiable from: https://bit.ly/3j91hVV
Hunter PR. Thrombosis after COVID-19 vaccination. BMJ. 2021;373:n958. https://doi.org/10.1136/bmj.n958 PMid:33853865
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;384(22):2092-101. https://doi.org/10.1056/NEJMoa2104840 PMid:33835769 PMCid:PMC8095372
United Kingdom, Public Health England. Guidance: covid-19 vaccination and blood clotting [Internet]. 2021 [updated 2021 May 21]. Avaiable from: https://bit.ly/3g78vaY
Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890. https://doi.org/10.1136/bmj.b2890 PMid:19679613 PMCid:PMC2726928
Pai M, Schull M, Razak F, et al. Vaccine-induced prothrombotic immune thrombocytopenia VIPIT following AstraZeneca COVID-19 vaccination: interim guidance for healthcare professionals in emergency department and inpatient settings. Science Briefs of the Ontario COVID-19 Science Advisory Table. 2021;1(21). https://doi.org/10.47326/ocsat.2021.02.21.1.0
Brasil, Ministério da Saúde, Agência Nacional de Vigilância Sanitária. Comunicado: suspensão da vacina da AstraZeneca para gestantes [Internet]. [published 2021 May 11; cited 2021 jun 9]. Avaiable from: https://bit.ly/3pCnmgx